Gene therapy for chronic granulomatous disease

Expert Opinion on Biological Therapy
Cecilia N BareseMary C Dinauer

Abstract

Chronic granulomatous disease (CGD) is a congenital immune deficiency that is a promising therapeutic target for gene replacement into haematopoietic stem cells (HSCs). CGD results from mutations in any one of four genes encoding subunits of the superoxide-generating NADPH oxidase of phagocytes. Life-threatening, recurrent bacterial and fungal infections, as well as inflammatory granulomas, are the hallmarks of the disease. NADPH oxidase activity can be reconstituted by retroviral- or lentiviral-mediated gene transfer to human CGD marrow in vitro and in xenograft transplant models. Gene transfer studies in knockout mouse models that resemble the human disease suggest that correction of oxidase activity in a minority of phagocytes will be of clinical benefit. Phase I clinical studies in unconditioned CGD patients showed transient expression of small numbers of gene-corrected neutrophils. Areas of research at present include efforts to enhance gene transfer rates into repopulating HSCs using vectors that transduce quiescent cells, and to increase the engraftment of genetically corrected HSCs using non-myeloablative conditioning and drug resistance genes for selection.

References

Oct 1, 1992·The Journal of Experimental Medicine·R E DonahueR Moen
Apr 1, 1992·British Journal of Haematology·K Cornetta
Dec 19, 1991·The New England Journal of Medicine·B L SchapiroM C Dinauer
Jul 1, 1995·Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics·J G LovasR A Miller
Apr 7, 1995·The Journal of Biological Chemistry·A R CrossJ T Curnutte
Nov 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·L ZhenM C Dinauer
Aug 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·S SekhsariaH L Malech
Mar 1, 1996·Molecular Medicine Today·A W Segal
Oct 1, 1996·European Journal of Pediatrics·M C CalviñoC Burgaleta
Oct 10, 1996·AIDS Research and Human Retroviruses·M AliM O McClure
Oct 29, 1997·Proceedings of the National Academy of Sciences of the United States of America·H L MalechJ I Gallin
Oct 15, 1998·Nature Medicine·J A AllayB P Sorrentino
Jun 4, 1999·The Journal of Pediatrics·D GoldblattI Russell-Eggitt
Jun 18, 1999·Gastroenterology Clinics of North America·R B Stein, S B Hanauer
Nov 7, 1999·Pediatric Radiology·F MacedoD Goldblatt
May 3, 2000·Clinical and Experimental Immunology·C M CaleD Goldblatt
Jun 9, 2000·Clinical and Experimental Dermatology·M M ChowdhuryC N Matthews
Aug 10, 2000·Bone Marrow Transplantation·M GrezJ P Hossle
Aug 10, 2000·Molecular Therapy : the Journal of the American Society of Gene Therapy·G GuenecheaJ E Dick
Nov 4, 2000·The Journal of Pediatrics·J LieseB H Belohradsky
Feb 13, 2001·Archives of Disease in Childhood·M G SchäppiP J Milla
Apr 17, 2001·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·J M BuddJ W Freeman

❮ Previous
Next ❯

Citations

Mar 13, 2010·International Journal of Hematology·Tang-Her JaingYung-Kuei Soong
Aug 9, 2006·Molecular Therapy : the Journal of the American Society of Gene Therapy·D Nicole WorshamDao Pan
Aug 30, 2006·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Marco A Yamazaki-NakashimadaFrancisco Espinosa-Rosales
Sep 1, 2011·Molecular Therapy : the Journal of the American Society of Gene Therapy·Hyoung Jin KangHyo Seop Ahn
Oct 3, 2007·Gene Therapy·B L AlexanderS Ylä-Herttuala
Apr 18, 2009·Proceedings of the National Academy of Sciences of the United States of America·I Scott RamseyDavid E Clapham
May 11, 2007·Journal of Paediatrics and Child Health·Donald S Anson, Janice M Fletcher
Jun 1, 2011·Clinical and Molecular Allergy : CMA·Eunkyung SongGuha Krishnaswamy
May 30, 2008·Seminars in Immunopathology·Marie José Stasia, Xing Jun Li
Jul 1, 2005·Expert Review of Clinical Immunology·Adrian J Thrasher, H Bobby Gaspar
Nov 24, 2007·Expert Opinion on Biological Therapy·Martin F RyserSebastian Brenner
Jan 15, 2010·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Donald B Kohn
Sep 28, 2005·The Journal of Investigative Dermatology·W Scott GoebelMary C Dinauer
Aug 19, 2008·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Baruch WolachDirk Roos
Jul 22, 2008·La Revue de médecine interne·M J StasiaI Durieu
Apr 22, 2008·Immunology and Allergy Clinics of North America·Adrian J Thrasher
Feb 6, 2008·The Veterinary Clinics of North America. Small Animal Practice·Peter Vajdovich
Jan 26, 2008·British Journal of Haematology·Reinhard A Seger
Jun 5, 2016·Molecular Pharmacology·Audry FernándezCarlos Gonzalez

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.